Therapeutic bedside monitoring of beta-lactam antibiotics in neonates with suspected or proven late onset sepsis: observational study

Description:

• Observational study in neonates and infants, Infants with chronological age < 90 days old with confirmed or suspected sepsis requiring treatment with study antibiotics (piperacillin/tazobactam, ceftazidime, cefepime or meropenem) will be included. 
• Study objective is to assess the ability to perform real-time monitoring of beta-lactam antibioticswith the MON4STRAT device in neonates and infants.

Funding: European Commission, under the FP7 programme

EUDRA-CT: 2018-000450-21

Link: www.mon4strat.ulg.ac.be

Partners:

• Université de Liège, Belgium; 
• Université catholique de Louvain, Belgium; 
• WOW Industries, Belgium;
• Institute of Cardiometabolism and Nutrition. France; 
• Servicio Madrileño de la Salud. Spain;
• University of Houston, USA;
• Université libre de Bruxelles , Belgium;
• Université Lille Nord de France CHRU-Lille, France; 
• EXPRIMO, Belgium; 
• AEPODIA, Belgium, 
• University of Tartu, Estonia
  

Project's status: